The acquisition would strengthen Cal-Maine’s presence across Texas and southern Oklahoma.  It will include purchase of commercial shell egg production and processing facilities of Mahard. Cal-Maine Foods Inc., a Jackson-base....

Japanese multinational conglomerate, Sony Corporation SNE recently sealed a transaction of USD 500 million to acquire AT&T’s T minority stake in GSN (Game Show Network). The newly made move is Sony’s concerted effort to focu....

The acquisition would strengthen Lineage’ strategic presence across Asia-Pacific.   It will also add 46 facilities in Australia, United States, Sri Lanka, Vietnam and New Zealand. Lineage Logistics Holdings LLC, one of the ....

The data shows a major statistical improvement in coronary flow reserve   Single-use CLBS16 can reportedly improve heart function and symptoms Caladrius Biosciences, Inc., a biopharmaceutical firm mainly focused on the developmen....

BRUKINSA is the first product from BeiGene to get approval from the FDA   84% of patients who are talking BRUKINSA have achieved an ORR BeiGene, Ltd., a biopharmaceutical firm focused on the development and commercialization of i....

The ongoing clinical trial of DCC-3014 have shown preliminary anti-tumor activity.    DCC-3014 validates emerging tolerability profile with no Grade 3 or Higher TEAEs.   Encore presentation of data from the INVICTUS Piv....

Merck will pay up to $576 million for the acquisition   Preclinical TRPML1 has the potential to treat neurodegenerative and lysosomal disorders COI Pharmaceuticals has recently announced that Merck, also called MSD outside Canada....

  The new launch of the services will help the company expand its oncology portfolio Personalis has been able to sequence more than 40,000 MVP samples since 2013. Personalis, Inc., a leading advanced genomics firm for cancer, rec....

Spinal muscular atrophy (SMA) is a genetic neuromuscular condition, affecting approx. 1 in 6,000 babies born globally each year. Numerous healthcare companies throughout the world are putting their best foot forward to develop an ....

Celltrion Healthcare, a biopharmaceutical company, recently announced data from a study further investigating efficacy, safety, immunogenicity & pharmacokinetics of CT-P13 SC, over a period of 1-year treatment. The study focuses on the ....